why choose us

First received: March 19, 2024

Clinical Trial: Inpatient Monitoring of Unfractionated Heparin

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Blood Clot
Thrombosis

Study Type: INTERVENTIONAL


Official Title: Inpatient Monitoring of Unfractionated Heparin

Brief Summary: Unfractionated heparin (UFH) is the most widely used intravenous (IV) anticoagulant for treating and preventing thromboembolic disease (e.g., blood clots ). UFH must be closely monitored and adjusted in the hospital. There are two assays used to monitor UFH: 1) the activated partial thromboplastin time (PTT) and 2) the chromogenic anti-factor Xa assay (anti-Xa). This study aims to compare PTT and anti-Xa methods for monitoring UFH in a pragmatic, randomized controlled trial to determine which helps patients reach…

Read more